{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:09:47Z","timestamp":1791900587746,"version":"4.3.4"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease (sAIBD). In addition to disease causing autoantibodies, several leukocyte subsets, including mast cells and eosinophils, play key roles in mediating skin inflammation. Detailed immunophenotyping and, more recently, the therapeutic effects of interleukin-4 (IL-4) receptor alpha inhibition in BP pointed to a prominent role of T helper 2 (Th2) cells. Among other cell types, IL-9 is expressed by Th2 and mast cells and potentially drives allergic, Th2-dominated inflammation. Although cytokines in BP have been relatively well investigated, the role of IL-9 has remained enigmatic. This study aimed to evaluate the effect of IL-9 in BP. Serum IL-9 levels were significantly elevated in patients with BP and decreased upon induction of remission. Serum IL-9 levels were not elevated in epidermolysis bullosa acquisita, another sAIBD. The time-course analysis using serum sets from four patients with BP revealed that serum IL-9 was a sensitive biomarker of BP. IL-9\u2013positive cells infiltrated dominantly in BP lesions, especially in the blister fluid, and Th9 cells were abundant. Therefore, IL-9 was elevated in the serum and lesions of BP, which could be a biomarker of BP.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1135002","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T04:47:31Z","timestamp":1686804451000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid"],"prefix":"10.3389","volume":"14","author":[{"given":"Hiroshi","family":"Koga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwesi","family":"Teye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norito","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takekuni","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17891","article-title":"Role of different pathways of the complement cascade in experimental bullous pemphigoid","volume":"116","author":"Nelson","year":"2006","journal-title":"J Clin Invest."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/all.13131","article-title":"Evidence for a role of eosinophils in blister formation in bullous pemphigoid","volume":"72","author":"de Graauw","year":"2017","journal-title":"Allergy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jdermsci.2015.03.002","article-title":"IgE autoantibodies in bullous pemphigoid: supporting role, or leading player","volume":"78","author":"Ujiie","year":"2015","journal-title":"J Dermatol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18364","article-title":"Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results","volume":"182","author":"Kamata","year":"2020","journal-title":"Br J Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri3824","article-title":"The development and in vivo function of T helper 9 cells","volume":"15","author":"Kaplan","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nri2848","article-title":"Cellular sources and immune functions of interleukin-9","volume":"10","author":"Noelle","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jaci.2015.01.021","article-title":"TH9 cells are required for tissue mast cell accumulation during allergic inflammation","volume":"136","author":"Sehra","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0812530106","article-title":"IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells","volume":"106","author":"Elyaman","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1749-6632.2011.06351.x","article-title":"From interleukin-9 to T helper 9 cells","volume":"1247","author":"Stassen","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2856","article-title":"Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells","volume":"18","author":"Purwar","year":"2012","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2013.01.006","article-title":"Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies","volume":"31","author":"Lo Schiavo","year":"2013","journal-title":"Clin Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15114","article-title":"Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid","volume":"177","author":"Hashimoto","year":"2017","journal-title":"Br J Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.718073","article-title":"Emerging biomarkers and therapeutic strategies for refractory bullous pemphigoid","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051752","article-title":"Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis","volume":"8","author":"Singh","year":"2013","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/cei.12198","article-title":"Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis","volume":"175","author":"Ma","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00281-016-0607-8","article-title":"T(H)9 cells in skin disorders","volume":"39","author":"Clark","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1784","article-title":"STAT3\/5-dependent IL9 overexpression contributes to neoplastic cell survival in mycosis fungoides","volume":"22","author":"Vieyra-Garcia","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444769","article-title":"Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita","volume":"45","author":"Kasprick","year":"2015","journal-title":"Eur J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00386","article-title":"The role of mast cells in autoimmune bullous dermatoses","volume":"9","author":"Yu","year":"2018","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00362","article-title":"Epidermolysis bullosa acquisita: the 2019 update","volume":"5","author":"Koga","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.jid.2020.01.022","article-title":"Epidermal damage induces Th1 polarization and defines the site of inflammation in murine epidermolysis bullosa acquisita","volume":"140","author":"Niebuhr","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2011.01378.x","article-title":"Lesional Th17 cells and regulatory T cells in bullous pemphigoid","volume":"20","author":"Arakawa","year":"2011","journal-title":"Exp Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.09.003","article-title":"IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid","volume":"96","author":"Chakievska","year":"2019","journal-title":"J Autoimmun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01238","article-title":"Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid","volume":"10","author":"Tasanen","year":"2019","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1135002\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T04:47:33Z","timestamp":1686804453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1135002\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":25,"alternative-id":["10.3389\/fimmu.2023.1135002"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1135002","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]},"article-number":"1135002"}}